ArticleDermatology practical & conceptual2025
Thyroid Dysfunction in Mycosis Fungoides: Sonographic and Laboratory Insights.
Article in Dermatology practical & conceptual, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThyroid gland affection in mycosis fungoides has rarely been reported. It occurs as extracutaneous involvement, incidentally, as a second malignancy, or as a side effect of systemic retinoids.
objectiveThis study aimed to specifically screen for biochemical or structural thyroid gland affection in a larger number of mycoses fungoides patients.
methodsTwenty-eight mycosis fungoides patients received a formal thyroid ultrasound examination, and their thyroid hormones and anti-thyroid peroxidase antibody levels were evaluated.
resultsHypoechogenic thyroid gland (suggesting thyroiditis) was detected in 39.3% of patients, and 39.3% had thyroid nodules. Thyroid hormones and anti-thyroid peroxidase antibodies were normal in 92.9% of patients. There was a statistically significant relationship between the mycosis fungoides variant and glandular echogenicity. Eighty percent of patients with the hypopigmented variant had hypoechoic gland, compared to 43.8 % of patients with the patch stage and none of the patients with the poikilodermatous variant (P=0.017*). There was a statistically significant relationship between the mycosis fungoides variant and DTD-TIRADS score (P=0.014*). The mean duration of mycosis fungoides was longer in patients with DTD-TIRADS III and IV and with thyroid nodules, however, without statistical significance. Patients treated with systemic psoralen ultraviolet A phototherapy, compared to narrow-band ultraviolet B phototherapy, were more likely to have thyroiditis, however, without statistical significance (P=0.265).
conclusionsWe recommend regular screening for thyroid gland affection in mycosis fungoides patients because of the possible association with thyroiditis and thyroid nodules, especially in patients with the hypopigmented variant.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.